Extreme Temps and CV Deaths; Big Bempedoic Acid Win; Interventional Cardiology Match

High systolic blood pressure remains the leading modifiable cardiovascular risk factor in the world, accounting for 10.8 million cardiovascular deaths and 11.3 million deaths overall in 2021, an international study showed. (Journal of the American College of Cardiology)

Extremely hot and cold temperatures were linked to excess cardiovascular deaths, particularly those from heart failure, in a study spanning five continents. (Circulation)

Based on 30-day readmission rates for heart failure, disparities by neighborhood household income have widened from 2010 to 2019. (JACC: Heart Failure)

Statin-intolerant patients saw reductions in cardiovascular events with bempedoic acid (Nexletol) in the CLEAR cardiovascular outcomes trial, according to Esperion.

Interventional cardiology is finally joining the National Resident Matching Program’s subspecialties Match system, with inaugural applications opening in July 2024 for the 2025 cycle, according to the Society for Cardiovascular Angiography & Interventions.

Real-world use of five transcatheter aortic valve replacement devices — Evolut R, Evolut PRO, Sapien 3, Acurate neo, and Portico — resulted in largely comparable outcomes. (Circulation: Cardiovascular Interventions)

Trials on transcatheter valve therapies tend to be conducted at participating hospitals with richer patients. (JAMA Cardiology)

People with depression were less likely to stick to their guideline-directed medical therapies after receiving percutaneous coronary intervention, a large cohort study showed. (JAMA Network Open)

Statin users had a lower risk of intracerebral hemorrhage strokes, according to the Danish nationwide registries. (Neurology)

These registries also suggested that people with simple congenital heart disease (CHD) had higher lifetime risks of neurologic, pulmonary, and other comorbidities. (European Heart Journal)

In the retrospective OSCAR study, rivaroxaban (Xarelto) matched apixaban (Eliquis) for the secondary prevention of cancer-associated thromboembolism, Janssen announced.

With no defibrillator reportedly available at the stadium, rescuers were unable to resuscitate sports journalist Grant Wahl when he collapsed during a World Cup match in Qatar. His cause of death is pending an autopsy. (New York Post)

Available evidence suggested that the increasing urbanization in Brazil is linked to a worsening of cardiometabolic health among Indigenous Brazilian people. (The Lancet)

Cardiologist Peter McCullough, MD, MPH, was among those who had their Twitter accounts reactivated after the platform scrapped its previous misinformation policy. (Daily Mail)

Scientists seeking the mechanism behind the effects of the GLP-1 receptor agonist liraglutide (Victoza) on atherosclerosis found it to be related to reduced plaque burden and vascular inflammation in mice. (JACC: Basic to Translational Science)